GeneNovate Investors' Day 2025

Gene and cell-based therapies (GCT) are among the most important topics for the future of biomedical research and clinical care for patients. The development of these innovative therapies, based on excellent research, is driving scientists from academia and industry alike. At the GeneNovate Investors' Day on 27th June 2025, we brought together emerging start-ups with investors, industry representatives, scientists and experts from politics and regulatory bodies. Together, we made a valuable contribution to the future of medicine.